Kastelan M - Search Results

1

Implications of Concurrent IDH1 and IDH2 Mutations on Survival in Glioma-A Case Report and Systematic Review.

Yuile A, Satgunaseelan L, Wei J, Kastelan M, Back MF, Lee M, Wei H, Buckland ME, Lee A, Wheeler HR. Yuile A, et al. Among authors: kastelan m. Curr Issues Mol Biol. 2022 Oct 21;44(10):5117-5125. doi: 10.3390/cimb44100348. Curr Issues Mol Biol. 2022. PMID: 36286062 Free PMC article.

2

Employment following chemoradiotherapy in glioblastoma: a prospective case series.

Gzell C, Wheeler H, Guo L, Kastelan M, Back M. Gzell C, et al. Among authors: kastelan m. J Cancer Surviv. 2014 Mar;8(1):108-13. doi: 10.1007/s11764-013-0311-9. Epub 2013 Nov 9. J Cancer Surviv. 2014. PMID: 24214496

3

Multigene profiling to identify alternative treatment options for glioblastoma: a pilot study.

Tabone T, Abuhusain HJ, Nowak AK; Australian Genomics and Clinical Outcome of Glioma (AGOG) Network; Erber WN, McDonald KL. Tabone T, et al. J Clin Pathol. 2014 Jul;67(7):550-5. doi: 10.1136/jclinpath-2014-202173. Epub 2014 Apr 2. J Clin Pathol. 2014. PMID: 24695838

4

Elderly patients aged 65-75 years with glioblastoma multiforme may benefit from long course radiation therapy with temozolomide.

Gzell C, Wheeler H, Guo L, Kastelan M, Back M. Gzell C, et al. Among authors: kastelan m. J Neurooncol. 2014 Aug;119(1):187-96. doi: 10.1007/s11060-014-1472-8. Epub 2014 May 15. J Neurooncol. 2014. PMID: 24830984

5

Large volume re-irradiation with bevacizumab is a feasible salvage option for patients with refractory high-grade glioma.

Back M, Gzell CE, Kastelan M, Guo L, Wheeler HR. Back M, et al. Among authors: kastelan m. Neurooncol Pract. 2015 Mar;2(1):48-53. doi: 10.1093/nop/npu031. Epub 2014 Dec 15. Neurooncol Pract. 2015. PMID: 26034641 Free PMC article.

6

Proliferation Index Predicts Survival after Second Craniotomy within 6 Months of Adjuvant Radiotherapy for High-grade Glioma.

Gzell C, Wheeler H, Huang D, Gaur P, Chen J, Kastelan M, Back M. Gzell C, et al. Among authors: kastelan m. Clin Oncol (R Coll Radiol). 2016 Mar;28(3):215-22. doi: 10.1016/j.clon.2015.08.009. Epub 2015 Sep 14. Clin Oncol (R Coll Radiol). 2016. PMID: 26382848

7

Small increases in enhancement on MRI may predict survival post radiotherapy in patients with glioblastoma.

Gzell CE, Wheeler HR, McCloud P, Kastelan M, Back M. Gzell CE, et al. Among authors: kastelan m. J Neurooncol. 2016 May;128(1):67-74. doi: 10.1007/s11060-016-2074-4. Epub 2016 Feb 15. J Neurooncol. 2016. PMID: 26879084

8

Survival Outcomes of Elderly Patients With Glioblastoma Multiforme in Their 75th Year or Older Treated With Adjuvant Therapy.

Harris G, Jayamanne D, Wheeler H, Gzell C, Kastelan M, Schembri G, Brazier D, Cook R, Parkinson J, Khasraw M, Louw S, Back M. Harris G, et al. Among authors: kastelan m. Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):802-810. doi: 10.1016/j.ijrobp.2017.02.028. Epub 2017 Feb 21. Int J Radiat Oncol Biol Phys. 2017. PMID: 28602411

9

Survival improvements with adjuvant therapy in patients with glioblastoma.

Jayamanne D, Wheeler H, Cook R, Teo C, Brazier D, Schembri G, Kastelan M, Guo L, Back MF. Jayamanne D, et al. Among authors: kastelan m. ANZ J Surg. 2018 Mar;88(3):196-201. doi: 10.1111/ans.14153. Epub 2017 Sep 18. ANZ J Surg. 2018. PMID: 28922698

10

Predicting patterns of failure in temporal lobe GBMs: possible implications on radiotherapy treatment portals.

Jayamanne D, Wheeler H, Brazier D, Newey A, Kastelan M, Guo L, Back M. Jayamanne D, et al. Among authors: kastelan m. Radiat Oncol. 2018 Jul 20;13(1):133. doi: 10.1186/s13014-018-1078-y. Radiat Oncol. 2018. PMID: 30029668 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters